• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者主动脉瓣狭窄的心血管死亡率的发生率、危险因素和预测因素。

Incidence, risk factors and predictors of cardiovascular mortality for aortic stenosis among patients with diabetes mellitus.

机构信息

Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University, Taipei, Taiwan.

Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Diabetes Res Clin Pract. 2022 Sep;191:110050. doi: 10.1016/j.diabres.2022.110050. Epub 2022 Aug 27.

DOI:10.1016/j.diabres.2022.110050
PMID:36030901
Abstract

AIMS

To find the incidence, risk factors and predictors of cardiovascular (CV) mortality for aortic stenosis (AS) in patients with type 2 diabetes mellitus (T2DM).

METHODS

Between 2014 and 2019, 20,979 patients with T2DM who underwent echocardiography were enrolled for analysis. The mean follow-up period was 34 months. Multiple risk factors and outcomes for patients with and without AS were presented.

RESULTS

AS was present in 776 (3.70%) patients. Age, female, chronic kidney disease, hyperlipidemia, and peripheral arterial disease statistically increased risk of AS. The CV mortality (adjusted hazard ratio [aHR] = 1.97; 95% confidence interval [CI] 1.336 - 2.906, p < 0.001) and risk of hospitalization for heart failure (HHF) (aHR = 1.73, 95% CI 1.442-2.082, p < 0.001) were significantly increased in patients with AS, without significant differences in acute myocardial infarction and stroke. Severity of AS, body mass index (<27 kg/m), hypertension, hyperuricemia, left ventricular dysfunction (ejection fraction < 50%), and hematocrit (<38%) were significantly associated with increased CV mortality and HHF.

CONCLUSIONS

AS was associated with an increased risk of CV mortality and HHF in patients with T2DM.

摘要

目的

探讨 2 型糖尿病(T2DM)患者主动脉瓣狭窄(AS)的发生率、危险因素和预测因素及其与心血管(CV)死亡率的关系。

方法

2014 年至 2019 年间,共纳入 20979 例行超声心动图检查的 T2DM 患者进行分析。平均随访时间为 34 个月。分析了患者有无 AS 时的多种危险因素和结局。

结果

20979 例患者中,776 例(3.70%)存在 AS。年龄、女性、慢性肾脏病、血脂异常和外周动脉疾病均与 AS 的发生风险呈统计学相关。AS 患者的 CV 死亡率(校正风险比[aHR] 1.97;95%置信区间 1.336-2.906,p<0.001)和心力衰竭住院风险(HHF)(aHR 1.73,95%置信区间 1.442-2.082,p<0.001)显著升高,但急性心肌梗死和卒中等发生率无显著差异。AS 严重程度、体质指数(<27kg/m)、高血压、高尿酸血症、左心室功能障碍(射血分数<50%)和红细胞压积(<38%)与 CV 死亡率和 HHF 的升高显著相关。

结论

T2DM 患者 AS 与 CV 死亡率和 HHF 风险增加相关。

相似文献

1
Incidence, risk factors and predictors of cardiovascular mortality for aortic stenosis among patients with diabetes mellitus.糖尿病患者主动脉瓣狭窄的心血管死亡率的发生率、危险因素和预测因素。
Diabetes Res Clin Pract. 2022 Sep;191:110050. doi: 10.1016/j.diabres.2022.110050. Epub 2022 Aug 27.
2
Depressed systemic arterial compliance and impaired left ventricular midwall performance in aortic stenosis with concomitant type 2 diabetes: a retrospective cross-sectional study.伴有 2 型糖尿病的主动脉瓣狭窄患者的系统性动脉顺应性降低和左心室中层功能障碍:一项回顾性横断面研究。
Cardiovasc Diabetol. 2019 Jul 17;18(1):92. doi: 10.1186/s12933-019-0894-1.
3
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial.西格列汀使用与 2 型糖尿病心力衰竭住院及相关结局的关系:一项随机临床试验的二次分析。
JAMA Cardiol. 2016 May 1;1(2):126-35. doi: 10.1001/jamacardio.2016.0103.
4
Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.射血分数降低的心力衰竭合并中度主动脉瓣狭窄患者。
J Am Coll Cardiol. 2021 Jun 8;77(22):2796-2803. doi: 10.1016/j.jacc.2021.04.014.
5
Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial.依帕列净对 2 型糖尿病合并已确诊动脉粥样硬化性心血管疾病患者心力衰竭相关事件的疗效:VERTIS CV 试验结果。
Circulation. 2020 Dec 8;142(23):2205-2215. doi: 10.1161/CIRCULATIONAHA.120.050255. Epub 2020 Oct 7.
6
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).根据心力衰竭和射血分数保留患者的糖尿病状态的临床和超声心动图特征和心血管结局:来自 I-Preserve 试验(伊贝沙坦治疗射血分数保留心力衰竭)的报告。
Circulation. 2017 Feb 21;135(8):724-735. doi: 10.1161/CIRCULATIONAHA.116.024593. Epub 2017 Jan 4.
7
Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials.2 型糖尿病患者心力衰竭住院发生率与主要动脉粥样硬化事件的关系:心血管结局试验的荟萃分析。
Diabetes Care. 2020 Oct;43(10):2614-2623. doi: 10.2337/dc20-0654.
8
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial.恩格列净降低了心力衰竭风险评分(TIMI-HF)分类下糖尿病患者的死亡率和心力衰竭住院风险:EMPA-REG OUTCOME 试验的事后分析。
Diabetes Obes Metab. 2020 Jul;22(7):1141-1150. doi: 10.1111/dom.14015. Epub 2020 Mar 29.
9
Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trial.预测冠心病合并糖耐量受损患者的心力衰竭事件:阿卡波糖心血管评估(ACE)试验的见解
Diabetes Res Clin Pract. 2020 Dec;170:108488. doi: 10.1016/j.diabres.2020.108488. Epub 2020 Oct 6.
10
Influence of patient gender on mortality after aortic valve replacement for aortic stenosis.主动脉瓣狭窄患者行主动脉瓣置换术后死亡率的性别影响。
J Thorac Cardiovasc Surg. 2011 Sep;142(3):595-601, 601.e1-2. doi: 10.1016/j.jtcvs.2010.05.056. Epub 2011 Jan 17.

引用本文的文献

1
Effect of Glucagon-like Peptide-1 Receptor Agonism on Aortic Valve Stenosis Risk: A Mendelian Randomization Analysis.胰高血糖素样肽-1受体激动对主动脉瓣狭窄风险的影响:一项孟德尔随机化分析
J Clin Med. 2024 Oct 26;13(21):6411. doi: 10.3390/jcm13216411.
2
Effect of body mass index on mortality for diabetic patients with aortic stenosis.体重指数对合并主动脉瓣狭窄的糖尿病患者死亡率的影响。
Aging (Albany NY). 2024 Jul 24;16(14):11359-11372. doi: 10.18632/aging.206018.
3
Association of cardio-renal biomarkers and mortality in the U.S.: a prospective cohort study.
美国心血管-肾脏生物标志物与死亡率的关联:一项前瞻性队列研究。
Cardiovasc Diabetol. 2023 Sep 29;22(1):265. doi: 10.1186/s12933-023-01986-2.